Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

A concerning number of newly diagnosed patients discontinue their medication within a year. Nearly 40% of patients diagnosed ...

A new agreement with OneTwo Analytics AB will allow Glucotrack to leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its continu ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can’t produce enough insulin.

A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

A 3-year-old pug in Mumbai received a continuous glucose monitor to track his high blood sugar levels. The CGM sensor, linked ...

RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...